Suppr超能文献

胃电刺激与胃切除术治疗药物难治性胃轻瘫的比较。

Gastric electric stimulator versus gastrectomy for the treatment of medically refractory gastroparesis.

机构信息

Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.

Keck School of Medicine of USC, Los Angeles, CA, USA.

出版信息

Surg Endosc. 2022 Oct;36(10):7561-7568. doi: 10.1007/s00464-022-09191-0. Epub 2022 Mar 25.

Abstract

BACKGROUND

Gastric electrical stimulation (GES) and laparoscopic gastrectomy (LG) are known therapeutic options for medically refractory gastroparesis (MRG) although there are limited data comparing their outcomes. We aim to compare clinical outcomes between patients undergoing GES vs upfront LG for the treatment of MRG while examining factors associated with GES failure and conversion to LG.

METHODS

We retrospectively analyzed 181 consecutive patients who underwent GES or LG for MRG at our institution from January 2003 to December 2017. Data collection consisted of chart review and follow-up telephone survey. Statistical analysis utilized Chi-squared, ANOVA, and multivariable logistic regression.

RESULTS

Overall, 130 (72%) patients underwent GES and 51 (28%) LG as primary intervention. GES patients were more likely to have diabetic gastroparesis (GES 67% vs LG 39%, p < 0.001), while primary LG patients were more likely to have post-surgical gastroparesis (GES 5% vs LG 43%, p < 0.001). Postoperatively, primary LG patients had higher rates of major in-hospital morbidity events (GES 5% vs LG 18%, p = 0.017) and longer hospital stays (GES 3 vs LG 9 days, p < 0.001). However, over a mean 35-month follow-up period, there were no differences in the rates of major morbidity, readmissions, or mortality. Multivariable regression analysis revealed patients undergoing GES as a primary intervention were less likely to report improvement in symptoms on follow-up compared to primary LG patients OR 0.160 (95% CI 0.048-0.532). Additionally, patients who converted to LG from GES were more likely to have post-surgical gastroparesis as the primary etiology.

CONCLUSION

GES as a first-line surgical treatment of MRG was associated with worse outcomes compared to LG. Post-surgical etiology was associated with an increased likelihood of GES failure, and in such patients, upfront gastrectomy may be a superior alternative to GES. Further studies are needed to determine patient selection for operative treatment of MRG.

摘要

背景

胃电刺激(GES)和腹腔镜胃切除术(LG)是治疗药物难治性胃轻瘫(MRG)的已知治疗方法,尽管比较两种方法治疗效果的资料有限。我们旨在比较 GES 与 LG 治疗 MRG 的临床结果,同时检查与 GES 失败和转为 LG 相关的因素。

方法

我们回顾性分析了 2003 年 1 月至 2017 年 12 月在我院接受 GES 或 LG 治疗的 181 例连续 MRG 患者的数据。数据收集包括病历回顾和随访电话调查。统计分析采用卡方检验、方差分析和多变量逻辑回归。

结果

总体而言,130 例(72%)患者接受 GES 作为一线治疗,51 例(28%)患者接受 LG 作为一线治疗。GES 患者更可能患有糖尿病性胃轻瘫(GES 67% vs LG 39%,p<0.001),而原发性 LG 患者更可能患有术后胃轻瘫(GES 5% vs LG 43%,p<0.001)。术后,原发性 LG 患者主要住院并发症发生率更高(GES 5% vs LG 18%,p=0.017),住院时间更长(GES 3 天 vs LG 9 天,p<0.001)。然而,在平均 35 个月的随访期间,主要发病率、再入院率或死亡率无差异。多变量回归分析显示,与原发性 LG 患者相比,接受 GES 作为一线治疗的患者在随访时报告症状改善的可能性较小 OR 0.160(95%CI 0.048-0.532)。此外,从 GES 转为 LG 的患者更有可能因术后胃轻瘫为主要病因。

结论

与 LG 相比,将 GES 作为治疗 MRG 的一线手术治疗方法与更差的结果相关。术后病因与 GES 失败的可能性增加相关,对于此类患者,胃切除术可能是 GES 的更好替代方案。需要进一步的研究来确定手术治疗 MRG 的患者选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验